|
1
|
Angus DC, Linde-Zwirble WT, Lidicker J,
Clermont G, Carcillo J and Pinsky MR: Epidemiology of severe sepsis
in the United States: Analysis of incidence, outcome, and
associated costs of care. Crit Care Med. 29:1303–1310. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bateman BT, Schmidt U, Berman MF and
Bittner EA: Temporal trends in the epidemiology of severe
postoperative sepsis after elective surgery: A large, nationwide
sample. Anesthesiology. 112:917–925. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hamano K, Gohra H, Noda H, Katoh T,
Fujimura Y, Zempo N and Esato K: Increased serum interleukin-8:
Correlation with poor prognosis in patients with postoperative
multiple organ failure. World J Surg. 22:1077–1081. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rubulotta FM, Ramsay G, Parker MM,
Dellinger RP, Levy MM and Poeze M: Surviving Sepsis Campaign
Steering Committee; European Society of Intensive Care Medicine;
Society of Critical Care Medicine: An international survey: Public
awareness and perception of sepsis. Crit Care Med. 37:167–170.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kawamoto T, Ii M, Kitazaki T, Iizawa Y and
Kimura H: Tak-242 selectively suppresses toll-like receptor
4-signaling mediated by the intracellular domain. Eur J Pharmacol.
584:40–48. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Biffl WL, Moore EE, Moore FA and Peterson
VM: Interleukin-6 in the injured patient. Marker of injury or
mediator of inflammation? Ann Surg. 224:647–664. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pape HC, Schmidt RE, Rice J, van Griensven
M, das Gupta R, Krettek C and Tscherne H: Biochemical changes after
trauma and skeletal surgery of the lower extremity: Quantification
of the operative burden. Crit Care Med. 28:3441–3418. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Giannoudis PV, Smith RM, Banks RE, Windsor
AC, Dickson RA and Guillou PJ: Stimulation of inflammatory markers
after blunt trauma. Br J Surg. 85:986–990. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stensballe J, Christiansen M, Tønnesen E,
Espersen K, Lippert FK and Rasmussen LS: The early IL-6 and IL-10
response in trauma is correlated with injury severity and
mortality. Acta Anaesthesiol Scand. 53:515–521. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Adib-Conquy M and Cavaillon JM:
Compensatory anti-inflammatory response syndrome. Thromb Haemost.
101:36–47. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sander M, Irwin M, Sinha P, Naumann E, Kox
WJ and Spies CD: Suppression of interleukin-6 to interleukin-10
ratio in chronic alcoholics: association with postoperative
infections. Intensive Care Med. 28:285–292. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ben-Neriah Y and Karin M: Inflammation
meets cancer, with NF-kB as the matchmaker. Nat Immunol.
12:715–723. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kagoya Y, Yoshimi A, Kataoka K, Nakagawa
M, Kumano K, Arai S, Kobayashi H, Saito T, Iwakura Y and Kurokawa
M: Positive feedback between NF-kB and TNF-α promotes
leukemia-initiating cell capacity. J Clin Invest. 124:528–542.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang X, Sun W, Shen W, Xia M, Chen C,
Xiang D, Ning B, Cui X, Li H, Li X, et al: Long non-coding RNA DILC
regulates liver cancer stem cells via IL-6/STAT3 axis. J Hepatol.
64:1283–1294. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Greenhill CJ, Rose-John S, Lissilaa R,
Ferlin W, Ernst M, Hertzog PJ, Mansell A and Jenkins BJ: IL-6
trans-signaling modulates TLR4-dependent inflammatory responses via
STAT3. J Immunol. 186:1199–1208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li RJ, Gao CY, Guo C, Zhou MM, Luo J and
Kong LY: The Anti-inflammatory Activities of two major withanolides
from physalisminima via acting on NF-κB, STAT3, and HO-1 in
LPS-stimulated RAW264.7 Cells. Inflammation. 40:401–413. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schroeder A, Herrmann A, Cherryholmes G,
Kowolik C, Buettner R, Pal S, Yu H, Müller-Newen G and Jove R: Loss
of androgen receptor expression promotes a stem-like cell phenotype
in prostate cancer through STAT3 signaling. Cancer Res.
74:1227–1237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Korkaya H, Kim GI, Davis A, Malik F, Henry
NL, Ithimakin S, Quraishi AA, Tawakkol N, D'Angelo R, Paulson AK,
et al: Activation of an IL6 inflammatory loop mediates trastuzumab
resistance in HER2+ breast cancer by expanding the cancer stem cell
population. Mol Cell. 47:570–584. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jinushi M, Chiba S, Yoshiyama H, Masutomi
K, Kinoshita I, Dosaka-Akita H, Yagita H, Takaoka A and Tahara H:
Tumor-associated macrophages regulate tumorigenicity and anticancer
drug responses of cancer stem/initiating cells. Proc Natl Acad Sci
USA. 108:12425–12430. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He G, Dhar D, Nakagawa H, Font-Burgada J,
Ogata H, Jiang Y, Shalapour S, Seki E, Yost SE, Jepsen K, et al:
Identification of liver cancer progenitors whose malignant
progression depends on autocrine IL-6 signaling. Cell. 155:384–396.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang WL, Yeh HH, Lin CC, Lai WW, Chang
JY, Chang WT and Su WC: Signal transducer and activator of
transcription 3 activation up-regulates interleukin-6 autocrine
production: A biochemical and genetic study of established cancer
cell lines and clinical isolated human cancer cells. Mol Cancer.
9:3092010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Judd LM, Bredin K, Kalantzis A, Jenkins
BJ, Ernst M and Giraud AS: STAT3 activation regulates growth,
inflammation, and vascularization in a mouse model of gastric
tumorigenesis. Gastroenterology. 131:1073–1085. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ogura H, Murakami M, Okuyama Y, Tsuruoka
M, Kitabayashi C, Kanamoto M, Nishihara M, Iwakura Y and Hirano T:
Interleukin-17 promotes autoimmunity by triggering a
positive-feedback loop via interleukin-6 induction. Immunity.
29:628–636. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sumimoto H, Imabayashi F, Iwata T and
Kawakami Y: The BRAF-MAPK signaling pathway is essential for
cancer-immune evasion in human melanoma cells. J Exp Med.
203:1651–1656. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao JW, Zhang AQ, Pan W, Yue CL, Zeng L,
Gu W and Jiang J: Association between IL-6-174G/C polymorphism and
the risk of sepsis and mortality: A systematic review and
meta-analysis. PLoS One. 10:e01188432015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Borden EC and Chin P: Interleukin-6: A
cytokine with potential diagnostic and therapeutic roles. J Lab
Clin Med. 123:824–829. 1994.PubMed/NCBI
|
|
30
|
Uusitalo-Seppälä R, Koskinen P, Leino A,
Peuravuori H, Vahlberg T and Rintala EM: Early detection of severe
sepsis in the emergency room: Diagnostic value of plasma C-reactive
protein, procalcitonin, and interleukin-6. Scand J Infect Dis.
43:883–890. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin YH, Hou W, Kang HS, Koh CS and Kim BS:
The role of interleukin-6 in the expression of PD-1 and PDL-1 on
central nervous system cells following infection with Theiler's
murine encephalomyelitis virus. J Virol. 87:11538–11551. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takeda K and Akira S: Toll-like receptors
in innate immunity. Int Immunol. 17:1–14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu D, Wan L, Chen M, Caudle Y, LeSage G,
Li Q and Yin D: Essential role of IL-10/STAT3 in chronic
stress-induced immune suppression. Brain Behav Immun. 36:118–127.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wittebole X, Coyle SM, Kumar A, Goshima M,
Lowry SF and Calvano SE: Expression of tumour necrosis factor
receptor and Toll-like receptor 2 and 4 on peripheral blood
leucocytes of human volunteers after endotoxin challenge: A
comparison of flow cytometric light scatter and immunofluorescence
gating. Clin Exp Immunol. 141:99–106. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Härter L, Mica L, Stocker R, Trentz O and
Keel M: Increased expression of toll-like receptor-2 and −4 on
leukocytes from patients with sepsis. Shock. 22:403–409. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hoebe K, Janssen E and Beutler B: The
interface between innate and adaptive immunity. Nat Immunol.
5:971–974. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kawai T and Akira S: The role of
pattern-recognition receptors in innate immunity: Update on
Toll-like receptors. Nat Immunol. 11:373–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kumar V and Sharma A: Innate immunity in
sepsis pathogenesis and its modulation: New immunomodulatory
targets revealed. J Chemother. 20:672–683. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Weighardt H, Kaiser-Moore S, Schlautkötter
S, Rossmann-Bloeck T, Schleicher U, Bogdan C and Holzmann B: Type I
IFN modulates host defense and late hyperinflammation in septic
peritonitis. J Immunol. 177:5623–5630. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Namath A and Patterson AJ: Genetic
polymorphisms in sepsis. Crit Care Clin. 25(835–856): x2009.
|
|
41
|
Tsujimoto H, Ono S, Efron PA, Scumpia PO,
Moldawer LL and Mochizuki H: Role of Toll-like receptors in the
development of sepsis. Shock. 29:315–321. 2008.PubMed/NCBI
|
|
42
|
Zhang J, Yang J, Xu X, Liang L, Sun H, Liu
G, Zhang L and Su Y: The influence of genetic polymorphisms in TLR4
and TIRAP, and their expression levels in peripheral blood, on
susceptibility to sepsis. Exp Ther Med. 11:131–139. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu X, Su X, Xu S, Wang H, Han D, Li J,
Huang M and Cao X: MicroRNA in vivo precipitation identifies
miR-151-3p as a computational unpredictable miRNA to target Stat3
and inhibits innate IL-6 production. Cell Mol Immunol. 15:99–110.
2018. View Article : Google Scholar : PubMed/NCBI
|
